The effects of the voglibose on non-alcoholic fatty liver disease in mice model

The α-glucosidase inhibitor (α-GI) delays the intestinal absorption of glucose, which reduces postprandial hepatic glucose intake. This mechanism is considered to be effective in treating non-alcoholic fatty liver disease (NAFLD). Here, we investigated the effect of voglibose, an α-glucosidase inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Jaehyun, Lee, Ji Young, Shin, Eugene, Lee, Minyoung, Lee, Yong-ho, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365779/
https://www.ncbi.nlm.nih.gov/pubmed/35948569
http://dx.doi.org/10.1038/s41598-022-15550-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365779/
https://www.ncbi.nlm.nih.gov/pubmed/35948569
http://dx.doi.org/10.1038/s41598-022-15550-7

Ejemplares similares